Advertisement

Topics

Immuno-oncology R&D company raises additional funding from Merck Ventures

06:17 EDT 24 Aug 2017 | EPM Magazine

Macrophage Pharma, an immune-oncology research and development (R&D) company that focuses on macrophage modulation in the tumour microenvironment (TME), has raised additional funding from Merck Ventures.

Original Article: Immuno-oncology R&D company raises additional funding from Merck Ventures

NEXT ARTICLE

More From BioPortfolio on "Immuno-oncology R&D company raises additional funding from Merck Ventures"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...